Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of British Columbia

$50,000.00

Development of new methodology for the synthesis of heterocyclic natural products

EF 2012-13

Résumé
Heterocyclic compounds (cyclic compounds that contain a heteroatom such as oxygen or nitrogen) are prevalent in and integral to a number of industries, such as pharmaceuticals, flavors, fragrances, and fine chemicals. Because the vast majority of new medicinal compounds contain heterocycles, the pharmaceutical industry (which generates roughly $550 billion in annual global sales revenue), has been actively seeking new efficient and cost-effective methods for their synthesis. Any increase in synthetic efficiency can lead to both a reduction in the production cost, thus lowering the price of the medicine, and the profound environmental benefit of less chemical waste. The goal of my research program is to develop innovative synthetic technology for the synthesis of heterocyclic compounds with current biomedical interest. Of particular interest is the rapid synthesis of synthetically modular oxygen- and nitrogen-containing heterocycles from which we can readily synthesize structural analogs for biological testing. We have successfully developed four new chemoselective cyclization methodologies and have successfully applied them to the synthesis of small, heterocyclic natural products. In the next five years we plan to utilize our methodology in the synthesis of larger, bioactive compounds. Furthermore, we plan to further develop and expand our radical methodology as well as explore new, non-radical methods for heterocycle synthesis.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
341648-2010
Name nom
Sammis, Glenn
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
50000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
3
Nb partie
5
Application title
Development of new methodology for the synthesis of heterocyclic natural products
Keyword
NSERC
Application summary
Heterocyclic compounds (cyclic compounds that contain a heteroatom such as oxygen or nitrogen) are prevalent in and integral to a number of industries, such as pharmaceuticals, flavors, fragrances, and fine chemicals. Because the vast majority of new medicinal compounds contain heterocycles, the pharmaceutical industry (which generates roughly $550 billion in annual global sales revenue), has been actively seeking new efficient and cost-effective methods for their synthesis. Any increase in synthetic efficiency can lead to both a reduction in the production cost, thus lowering the price of the medicine, and the profound environmental benefit of less chemical waste. The goal of my research program is to develop innovative synthetic technology for the synthesis of heterocyclic compounds with current biomedical interest. Of particular interest is the rapid synthesis of synthetically modular oxygen- and nitrogen-containing heterocycles from which we can readily synthesize structural analogs for biological testing. We have successfully developed four new chemoselective cyclization methodologies and have successfully applied them to the synthesis of small, heterocyclic natural products. In the next five years we plan to utilize our methodology in the synthesis of larger, bioactive compounds. Furthermore, we plan to further develop and expand our radical methodology as well as explore new, non-radical methods for heterocycle synthesis.